NCT06311461

Brief Summary

The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina. This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women and men with angina, targeting additional angina burden borne of social disadvantage Participants will be randomized to a 10-acupuncture session protocol, two treatments per week for five weeks, or an attention control group. Participants will view designated, non-pain related Technology, Entertainment, Design Talks equal to the time spent receiving acupuncture (\~7.5-10 hrs.). The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Apr 2024Jun 2027

First Submitted

Initial submission to the registry

February 21, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2.8 years

First QC Date

February 21, 2024

Last Update Submit

March 30, 2025

Conditions

Outcome Measures

Primary Outcomes (10)

  • Pain Now

    numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable right now

    Baseline to 10 weeks

  • Worst Pain

    numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable

    Baseline to 10 weeks

  • Least Pain

    numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable

    Baseline to 10 weeks

  • Acute Coronary Syndrome like symptoms (ACS Symptom Checklist)

    Change in Acute coronary syndrome type symptoms. (13 individual symptoms measured dichotomously, 0=no, did not experience, 1=yes, did experience),

    Baseline to 10 weeks

  • Anginal Pain (Seattle Angina Questionnaire-7)

    Participants will be asked: Over the past 4 weeks, on average, how many times have you had chest pain, chest tightness, or angina? 6 point scale. HIgher number is better.

    Baseline to 10 weeks

  • Number of Angina Attacks (From American Heart Association Angina Log)

    How many times the participant has had angina

    Baseline to 10 weeks

  • Symptom Triggers (From American Heart Association Angina Log)

    Participant will be Asked: What triggered the angina attack?

    Baseline to 10 weeks

  • Pain from Angina Attack (From American Heart Association Angina Log)

    4-point scale. 1-little pain to 4-severe pain.

    Baseline to 10 weeks

  • Length of Angina Attack (American Heart Association Angina Log)

    In minutes

    Baseline to 10 weeks

  • Self-treatment for Symptoms (From American Heart Association Angina Log)

    Participants will be asked to list strategies they used to mitigate pain

    Baseline to 10 weeks

Secondary Outcomes (7)

  • Functional Status Related to Angina (Seattle Angina Questionnaire-7)

    Baseline and study completion (10 weeks)

  • General Functional Status (PROMIS 29v.2)

    Baseline and study completion (10 weeks)

  • Quality of Life (Seattle Angina Questionnaire-7)

    Baseline and study completion (10 weeks)

  • Use of Nitrates and Analgesics (AHA Angina log)

    Baseline and study completion (10 weeks)

  • Patient Reported Outcomes (Patient Reported Outcomes Measurement Information System-29v.2

    Baseline and study completion (10 weeks)

  • +2 more secondary outcomes

Study Arms (2)

Acupuncture

EXPERIMENTAL

Participants in the acupuncture group will receive a standardized Traditional Chinese Medicine (TCM) point prescription. Acupuncture will be administered 2 times per week for 5 weeks for a total of 10 treatments.

Procedure: Acupuncture

Attention Control Group

ACTIVE COMPARATOR

The attention control group will view non-pain related TED talk videos over 5 weeks approximately equal to 10 hours of treatment for the acupuncture group.

Other: Attention control

Interventions

AcupuncturePROCEDURE

The acupuncturist will swab each point with alcohol. Needles will be inserted and retained for 30 minutes. Each needle will be rotated 3 times to stimulate the qi in the meridian; 10 minutes after insertion, 20 minutes after insertion, and just prior to removal at 30 minutes. Needles will be inserted using the standards of clean needle technique established by the Council of Colleges of Acupuncture and Oriental Medicine. One size acupuncture needle, 0.25 diameter Ă— 40 mm length, will be used. All acupuncture needles are sterile, disposable, and made of surgical stainless steel with stainless steel wound heads. Sessions will be repeated twice weekly (with at least 2 off days in between) for 5 weeks (10 sessions).

Acupuncture

Viewing non-pain related TED talk videos over 5 weeks approximately equal to 10 hours of treatment for the acupuncture group.

Attention Control Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body)
  • Treated with medical therapy for at least 1 month
  • Experiencing symptoms at least once per week
  • Speak and read English
  • years of age minimum

You may not qualify if:

  • Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy
  • Physical or cognitive limitations that will prevent informed consent or completion of study tasks
  • Use of steroid or prescription analgesic medications
  • Concomitant biofeedback, professional massage and acupuncture.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA School of Nursing

Los Angeles, California, 90095, United States

RECRUITING

Related Publications (1)

  • Nelson KA, Mirzaei S, Schlaeger JM, Li H, Burke L, Cabezas P, Meinel M, Rountree L, Su S, DeVon HA. Designing an Attention Control Condition for a Randomized Controlled Trial Using TED Talks. West J Nurs Res. 2025 Aug;47(8):764-769. doi: 10.1177/01939459251342753. Epub 2025 May 26.

Related Links

MeSH Terms

Conditions

Angina, Stable

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Holli A. DeVon, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Holli A. DeVon, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 21, 2024

First Posted

March 15, 2024

Study Start

April 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

The dataset will include self-reported demographic information, clinical data, and biological data. The final dataset will be stripped of identifiers and made available to share with other qualified scientists or trainees.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
2 years following termination of the study for a length of 5 years.
Access Criteria
We will make the data available to qualified scientists, predoctoral students, or postdoctoral trainees only under a data-sharing agreement that provides for a commitment to: 1) use the data for research purposes only; 2) secure the dataset appropriately; 3) destroy or return the data after analyses are complete, 4) share the findings with the PIs; and 5) make every effort to present and publish findings with the scientific community.

Locations